UBS Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.2M Buy
4,024,646
+2,270,084
+129% +$35.1M 0.01% 1046
2025
Q1
$26.1M Buy
1,754,562
+92,930
+6% +$1.38M ﹤0.01% 1617
2024
Q4
$22M Buy
1,661,632
+1,588,617
+2,176% +$21M ﹤0.01% 1681
2024
Q3
$1.04M Sell
73,015
-41,456
-36% -$590K ﹤0.01% 3565
2024
Q2
$1.48M Buy
114,471
+18,244
+19% +$236K ﹤0.01% 3085
2024
Q1
$1.34M Buy
96,227
+33,138
+53% +$460K ﹤0.01% 3337
2023
Q4
$900K Buy
63,089
+11,704
+23% +$167K ﹤0.01% 3521
2023
Q3
$795K Sell
51,385
-158,520
-76% -$2.45M ﹤0.01% 3271
2023
Q2
$3.3M Buy
209,905
+127,439
+155% +$2M ﹤0.01% 2250
2023
Q1
$1.36M Sell
82,466
-33,686
-29% -$555K ﹤0.01% 2932
2022
Q4
$1.81M Sell
116,152
-7,852
-6% -$122K ﹤0.01% 2636
2022
Q3
$1.61M Buy
124,004
+9,703
+8% +$126K ﹤0.01% 2509
2022
Q2
$1.61M Buy
114,301
+7,901
+7% +$111K ﹤0.01% 2539
2022
Q1
$1.52M Sell
106,400
-204,280
-66% -$2.93M ﹤0.01% 2879
2021
Q4
$4.23M Buy
310,680
+39,371
+15% +$537K ﹤0.01% 2241
2021
Q3
$4.44M Buy
271,309
+17,192
+7% +$282K ﹤0.01% 2108
2021
Q2
$4.28M Sell
254,117
-13,065
-5% -$220K ﹤0.01% 2149
2021
Q1
$4.88M Buy
267,182
+166,659
+166% +$3.04M ﹤0.01% 1977
2020
Q4
$1.83M Buy
100,523
+17,079
+20% +$311K ﹤0.01% 2692
2020
Q3
$1.49M Sell
83,444
-3,502
-4% -$62.5K ﹤0.01% 2654
2020
Q2
$1.56M Buy
86,946
+15,006
+21% +$269K ﹤0.01% 2481
2020
Q1
$1.09M Buy
71,940
+676
+0.9% +$10.3K ﹤0.01% 2596
2019
Q4
$1.41M Sell
71,264
-3,238
-4% -$63.9K ﹤0.01% 3058
2019
Q3
$1.28M Sell
74,502
-13,848
-16% -$238K ﹤0.01% 3001
2019
Q2
$1.56M Sell
88,350
-136,367
-61% -$2.41M ﹤0.01% 2707
2019
Q1
$4.58M Sell
224,717
-9,923,879
-98% -$202M ﹤0.01% 1833
2018
Q4
$171M Buy
+10,148,596
New +$171M 0.08% 194